source url Another Strong Day in Life Science Stocks
Carl Icahn, activist investor takes a 13% stake in Hologic. Hologic (HOLX $22.82) was added to our portfolio on 4/9/13 but has been a laggard due to earnings misses. The stock is up 2.4% on a volume of 25M shares.
Many stocks in our Dx and Tools portfolio are having a good day today:
http://wildwooddesigns.com.au/tag/driftwood-furniture/ Cardiovascular Systems (CSII $33.65) up 8.9%, Cepheid (CPHD $43.76) up 2.2%, Exact Sciences (EXAS $11.46) up 3.2%, Genomic Health (GHDX $35.79) and Illumina (ILMN $96.39) up 4%.
Last week we added see url 4 new trading ideas in the DX sector and we will review all of them beginning with NanoString Technologies, Inc. (NSTG $12.09) later today. Nanostring is a proprietary life science tools platform that can be used for translational research to validate discoveries and translate them into useful clinical diagnostic assays.
Here are the four diagnostic stocks mentioned in a post last week and their prices:
New Long Ideas (from 11/14/13)
We are giving you a “heads-up” on four new trading ideas. We know all of these companies but need to do a little more work on entry price, financials and technicals. These stocks can be volatile and some have already run up. Each of these companies has unique strengths. We will provide a sketch of each Company and rationale for investment: Luminex (LMNX $19), Meridian Bioscience (VIVO $25.5), Nanosphere (NSPH $2.15) and NanoString (NSTG $11.3).
Luminex and Meridian are small cap value ; Nanosphere is a turnaround; Nanostring is a recent IPO and early stage growth.